Correction to “Exenatide for weight-loss maintenance in adolescents with severe obesity: A randomized, placebo-controlled trial”

IF 4.2 2区医学 Q1 ENDOCRINOLOGY & METABOLISM

Obesity Pub Date : 2023-08-10 DOI:10.1002/oby.23843

引用次数: 0

Abstract

Fox CK, Clark JM, Rudser KD, et al. Exenatide for weight-loss maintenance in adolescents with severe obesity: A randomized, placebo-controlled trial. Obesity (Silver Spring). 2022;30:1105-1115.

On page 1112, Table 2 was incorrect because of interchanged data from “BMI (kg/m²)” and “Percent of 95th BMI percentile.”

Below is the correct Table 2:

We apologize for this error.

查看原文本刊更多论文

更正“艾塞那肽用于严重肥胖青少年的减肥维持:一项随机、安慰剂对照试验”

Fox CK, Clark JM, Rudser KD，等。艾塞那肽用于严重肥胖青少年的减肥维持:一项随机、安慰剂对照试验。肥胖(银泉)。2022; 30:1105 - 1115。在第1112页，由于“BMI (kg/m2)”和“第95个BMI百分位数的百分比”的数据互换，表2是不正确的。下面是正确的表2:我们为这个错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Obesity 医学-内分泌学与代谢

CiteScore

11.70

自引率

1.40%

发文量

261

审稿时长

2-4 weeks

期刊介绍： Obesity is the official journal of The Obesity Society and is the premier source of information for increasing knowledge, fostering translational research from basic to population science, and promoting better treatment for people with obesity. Obesity publishes important peer-reviewed research and cutting-edge reviews, commentaries, and public health and medical developments.